Tilray to provide cannabis for Spanish clinical study on severe brain cancer

Mugglehead
By Rowan DunneOct 16, 2023, 7:42 pm164 pts
Tilray Medical, a subsidiary of Tilray Brands, Inc. (Nasdaq: TLRY) (TSX: TLRY), will be supplying cannabis extract for a new clinical trial in Spain aimed at combatting a severe form of brain cancer. On Monday, the major cannabis company announced its sponsorship of the upcoming study on glioblastoma. The…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Fluence Debuts SPYDR 3: Pioneering Fixture Upgrades Output and Efficiency for Cannabis Growers 67

Legal Pot Delivery 101: A Beginner’s Guide to Cannabis at Your Door 63

Lawmakers urge Trump to act on cannabis 60

Grön, Head Change Debut Exclusive Solventless Edibles in Missouri 29

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.